Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREPACOL2: MBP and Oral Antibiotics in Rectal Cancer Surgery
NCT03491540Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2018
- Primary completion
- Oct 2023
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gentamicin and ornidazole in surgical site infection (SSI) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Postoperative surgical site infection at 30 days. Started Sep 2018; status: completed.
02
Drugs
gentamicinornidazole
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03491540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03491540.